MNKD MannKind Corporation - Common Stock
MannKind Corporation - Common Stock について Wikipediaからの企業概要
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
続きを読む
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
MNKD 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
MNKD 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
MNKD アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 4 28.6%
- 買い 8 57.1%
- 保有 2 14.3%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
8 アナリスト · 2026-08-17決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $-0.06 | $-0.00 | -0.06% |
| 2026年3月31日 | $-0.05 | $-0.00 | -0.05% |
| 2025年12月31日 | $-0.05 | $0.01 | -0.06% |
| 2025年9月30日 | $0.07 | $0.02 | 0.05% |
| 2025年6月30日 | $0.00 | $0.05 | -0.05% |
| 2025年3月31日 | $0.04 | $0.04 | -0.00% |
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
貸借対照表 28
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
キャッシュフロー 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
流動性と支払能力 4
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
成長率 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM) 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
貸借対照表 25
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
キャッシュフロー 11
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
流動性と支払能力 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
バリュエーション(TTM) 9
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $349M | $286M | $199M | $100M | $75M |
| 営業利益率 % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| 純利益 | $6M | $28M | $-12M | $-87M | $-81M |
| 希薄化後EPS | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流動比率 | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| クイックレシオ | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $14M | $33M | $-8M | $-88M | $-73M |
最新ニュース この会社に言及した最近の見出し
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家(13F) 271 提出者 · $560.6M合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 55 (+12 前期比) | 37 (-11 前期比) | 93 (+10 前期比) | 61 (-8 前期比) | +24.2M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| Rubric Capital Management LP | $76,680,000 | 18,000,000 | 13.68% | 株式数 |
| STATE STREET CORP | $68,901,423 | 16,174,043 | 12.29% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $56,101,610 | 13,169,392 | 10.01% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $29,027,881 | 6,812,460 | 5.18% | 株式数 |
| Frazier Life Sciences Management, L.P. | $28,116,000 | 6,600,000 | 5.01% | 株式数 |
| Deep Track Capital, LP | $25,560,000 | 6,000,000 | 4.56% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $23,099,232 | 5,422,355 | 4.12% | 株式数 |
| 180 WEALTH ADVISORS, LLC | $21,126,835 | 4,959,351 | 3.77% | 株式数 |
| FMR LLC | $17,455,563 | 4,097,550 | 3.11% | 株式数 |
| TSP Capital Management Group, LLC | $16,923,596 | 3,972,675 | 3.02% | 株式数 |
| BRAIDWELL LP | $14,732,908 | 3,458,429 | 2.63% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12,789,240 | 3,002,169 | 2.28% | 株式数 |
| VANGUARD GROUP INC | $11,888,249 | 2,096,693 | 2.12% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $11,475,213 | 2,693,712 | 2.05% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11,070,577 | 2,598,727 | 1.97% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $9,358,279 | 2,196,779 | 1.67% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $8,689,749 | 2,039,847 | 1.55% | 株式数 |
| GOLDMAN SACHS GROUP INC | $6,332,618 | 1,486,530 | 1.13% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,030,221 | 1,180,803 | 0.90% | 株式数 |
| BlackRock, Inc. | $4,766,748 | 1,118,955 | 0.85% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $4,486,321 | 1,053,127 | 0.80% | 株式数 |
| Caption Management, LLC | $4,260,000 | 1,000,000 | 0.76% | プットオプション |
| J. Goldman & Co LP | $3,478,669 | 816,589 | 0.62% | 株式数 |
| WELLS FARGO & COMPANY/MN | $3,473,987 | 815,490 | 0.62% | 株式数 |
| SCOPIA CAPITAL MANAGEMENT LP | $2,960,534 | 694,961 | 0.53% | 株式数 |
| Balyasny Asset Management L.P. | $2,914,296 | 684,107 | 0.52% | 株式数 |
| TWO SIGMA ADVISERS, LP | $2,897,166 | 510,964 | 0.52% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $2,771,407 | 650,565 | 0.49% | 株式数 |
| Swiss National Bank | $2,502,324 | 587,400 | 0.45% | 株式数 |
| STATE OF WISCONSIN INVESTMENT BOARD | $2,177,052 | 511,045 | 0.39% | 株式数 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2,106,540 | 494,493 | 0.38% | 株式数 |
| 1492 Capital Management LLC | $2,052,136 | 481,722 | 0.37% | 株式数 |
| Mariner, LLC | $2,020,189 | 474,236 | 0.36% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $1,836,597 | 431,126 | 0.33% | 株式数 |
| Schonfeld Strategic Advisors LLC | $1,774,216 | 416,483 | 0.32% | 株式数 |
| Squarepoint Ops LLC | $1,759,644 | 413,062 | 0.31% | 株式数 |
| Jefferies Financial Group Inc. | $1,694,202 | 397,700 | 0.30% | 株式数 |
| ExodusPoint Capital Management, LP | $1,666,261 | 391,141 | 0.30% | 株式数 |
| JANE STREET GROUP, LLC | $1,658,418 | 389,300 | 0.30% | コールオプション |
| Man Group plc | $1,624,023 | 381,226 | 0.29% | 株式数 |
| RHUMBLINE ADVISERS | $1,604,647 | 376,681 | 0.29% | 株式数 |
| IEQ CAPITAL, LLC | $1,544,607 | 362,584 | 0.28% | 株式数 |
| CITIGROUP INC | $1,499,243 | 351,935 | 0.27% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,423,692 | 334,200 | 0.25% | プットオプション |
| Bank of New York Mellon Corp | $1,422,222 | 333,855 | 0.25% | 株式数 |
| Caption Management, LLC | $1,414,231 | 331,979 | 0.25% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,359,221 | 319,066 | 0.24% | 株式数 |
| ALPS ADVISORS INC | $1,330,615 | 312,351 | 0.24% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,216,230 | 285,500 | 0.22% | コールオプション |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,029,075 | 241,567 | 0.18% | 株式数 |
| BARCLAYS PLC | $1,029,062 | 241,564 | 0.18% | 株式数 |
| Rafferty Asset Management, LLC | $1,008,640 | 236,770 | 0.18% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $1,002,715 | 235,379 | 0.18% | 株式数 |
| Aaron Wealth Advisors LLC | $1,000,878 | 234,948 | 0.18% | 株式数 |
| HSBC HOLDINGS PLC | $998,560 | 230,881 | 0.18% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930,294 | 379,712 | 0.17% | 株式数 |
| CITADEL ADVISORS LLC | $928,680 | 218,000 | 0.17% | コールオプション |
| CITADEL ADVISORS LLC | $898,860 | 211,000 | 0.16% | プットオプション |
| Bruce & Co., Inc. | $831,011 | 195,073 | 0.15% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $775,060 | 181,939 | 0.14% | 株式数 |
| MetLife Investment Management, LLC | $766,442 | 179,916 | 0.14% | 株式数 |
| FRANKLIN RESOURCES INC | $755,021 | 177,235 | 0.13% | 株式数 |
| Stonepine Capital Management, LLC | $750,000 | 250,000 | 0.13% | コールオプション |
| UBS Group AG | $715,978 | 168,070 | 0.13% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $693,375 | 283,010 | 0.12% | 株式数 |
| MORGAN STANLEY | $651,282 | 152,883 | 0.12% | 株式数 |
| TUDOR INVESTMENT CORP ET AL | $640,657 | 150,389 | 0.11% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $632,009 | 148,359 | 0.11% | 株式数 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613,437 | 171,372 | 0.11% | 株式数 |
| Jain Global LLC | $604,673 | 141,942 | 0.11% | 株式数 |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590,457 | 138,605 | 0.11% | 株式数 |
| Susquehanna Portfolio Strategies, LLC | $574,538 | 134,868 | 0.10% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570,354 | 133,886 | 0.10% | 株式数 |
| MERCER GLOBAL ADVISORS INC /ADV | $557,723 | 130,921 | 0.10% | 株式数 |
| PROFUND ADVISORS LLC | $517,726 | 121,532 | 0.09% | 株式数 |
| Invesco Ltd. | $512,389 | 120,279 | 0.09% | 株式数 |
| Vanguard Global Advisers, LLC | $509,833 | 119,679 | 0.09% | 株式数 |
| KLP KAPITALFORVALTNING AS | $491,604 | 115,400 | 0.09% | 株式数 |
| Gotham Asset Management, LLC | $452,463 | 106,212 | 0.08% | 株式数 |
| State of New Jersey Common Pension Fund D | $403,171 | 94,641 | 0.07% | 株式数 |
| State of Wyoming | $403,149 | 94,636 | 0.07% | 株式数 |
| Police & Firemen's Retirement System of New Jersey | $386,834 | 90,806 | 0.07% | 株式数 |
| Amundi | $374,310 | 87,866 | 0.07% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373,478 | 87,671 | 0.07% | 株式数 |
| NEW YORK STATE COMMON RETIREMENT FUND | $359,966 | 84,499 | 0.06% | 株式数 |
| ARIZONA STATE RETIREMENT SYSTEM | $344,050 | 80,763 | 0.06% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338,155 | 79,379 | 0.06% | 株式数 |
| Aquatic Capital Management LLC | $335,300 | 78,709 | 0.06% | 株式数 |
| Rockefeller Capital Management L.P. | $332,996 | 78,168 | 0.06% | 株式数 |
| Vanguard Investments Australia, Ltd. | $314,929 | 73,927 | 0.06% | 株式数 |
| JANUS HENDERSON GROUP PLC | $313,658 | 127,763 | 0.06% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312,203 | 73,287 | 0.06% | 株式数 |
| Sequoia Financial Advisors, LLC | $296,935 | 69,703 | 0.05% | 株式数 |
| INTECH INVESTMENT MANAGEMENT LLC | $284,653 | 66,820 | 0.05% | 株式数 |
| COMMONWEALTH EQUITY SERVICES, LLC | $280,421 | 65,827 | 0.05% | 株式数 |
| China Universal Asset Management Co., Ltd. | $262,714 | 61,670 | 0.05% | 株式数 |
| LPL Financial LLC | $260,060 | 61,047 | 0.05% | 株式数 |
| SIMPLEX TRADING, LLC | $258,790 | 60,749 | 0.05% | 株式数 |
| Cetera Investment Advisers | $241,546 | 56,701 | 0.04% | 株式数 |
| Painted Porch Advisors LLC | $227,620 | 53,432 | 0.04% | 株式数 |
企業インサイダー 43 人のインサイダー · 27人の役員 · 18人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 2026年7月15日 M | 2,433,779 | 1 | 4 | $-990,292 |
| Hakan Edstrom | President & CEO | 2015年8月27日 A | 1,114,340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 2026年7月15日 F | 318,668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 2015年8月27日 A | 106,539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 2026年7月15日 F | 343,398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 2026年7月15日 M | 478,966 | 0 | 1 | $-94,448 |
| Stuart A Tross | Chief People & Workpl Officer | 2026年7月15日 M | 1,058,142 | 0 | 2 | $-548,528 |
| David Thomson | EVP Genl Counsel & Secretary | 2026年7月15日 M | 797,554 | 0 | 3 | $-930,755 |
| Ajay Ahuja | Chief Medical Officer | 2026年3月23日 A | 318,200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 2025年7月15日 F | 349,841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 2025年7月15日 F | 460,791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 2022年8月27日 F | 745,233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 2022年2月28日 A | 576,690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 2020年8月27日 A | 167,119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 2020年7月31日 P | 41,059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 2020年2月25日 A | 83,972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 2019年7月31日 P | 29,584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 2019年5月14日 A | 43,012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 2017年8月10日 S | 2,924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 2016年2月18日 A | 92,200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 2015年8月22日 F | 1,005,990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 2015年2月23日 F | 50,624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 2012年3月3日 F | 133,611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 2008年11月16日 F | 204,401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 2008年8月13日 A | 14,650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 2006年12月8日 A | 14,800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 2004年8月19日 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | 取締役 | 2026年5月20日 A | 265,600 | 0 | 0 | $0 |
| Jennifer Grancio | 取締役 | 2026年5月20日 A | 244,815 | 0 | 0 | $0 |
| James Samuel Shannon | 取締役 | 2026年5月20日 A | 64,635 | 0 | 0 | $0 |
| Michael A Friedman | 取締役 | 2026年5月20日 A | 47,500 | 0 | 0 | $0 |
| Anthony C Hooper | 取締役 | 2026年5月20日 A | 236,153 | 0 | 0 | $0 |
| Christine Mundkur | 取締役 | 2026年5月20日 A | 254,493 | 0 | 0 | $0 |
| Ronald J Consiglio | 取締役 | 2026年5月20日 A | 132,342 | 0 | 0 | $0 |
| Kent Kresa | 取締役 | 2024年5月15日 A | 274,541 | 0 | 0 | $0 |
| Henry L Nordhoff | 取締役 | 2019年5月14日 A | 103,426 | 0 | 0 | $0 |
| David Maccallum | 取締役 | 2018年5月16日 A | 114,790 | 0 | 0 | $0 |
| Matthew J Pfeffer | 取締役 | 2017年8月28日 F | 81,961 | 0 | 0 | $0 |
| Abraham E Cohen | 取締役 | 2012年8月17日 S | 56,424 | 0 | 0 | $0 |
| Heather Hay Murren | 取締役 | 2008年8月13日 A | 10,100 | 0 | 0 | $0 |
| Kathleen Connell | 取締役 | 2006年5月25日 A | — | 0 | 0 | $0 |
| Llew Keltner | 取締役 | 2006年5月25日 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 2026年8月7日 S | 785,867 | 0 | 3 | $-427,369 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 2保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 提出書類 | 2012年7月10日 | — | 初回提出 | 受動的投資 | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2006年1月31日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 41のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1.43% | 773,251 NS | 2026年4月30日 | N-PORT |
| SBIO · ALPS ETF Trust | 0.74% | 317,578 NS | 2026年5月31日 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.54% | 29,662 SH | 2026年8月8日 | 日次 |
| AGNG · Global X Funds | 0.46% | 98,947 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.34% | 625,921 NS | 2026年4月30日 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.11% | 64,525 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.09% | 2,170,137 SH | 2026年8月8日 | 日次 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.09% | 16,814 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 330,117 SH | 2026年8月8日 | 日次 |
| IWO · iShares Trust | 0.07% | 2,772,931 SH | 2026年8月8日 | 日次 |
| ESML · iShares Trust | 0.06% | 449,515 SH | 2026年8月8日 | 日次 |
| BIB · ProShares Trust | 0.06% | 11,389 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 114,273 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 1,771,496 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.04% | 7,830,029 SH | 2026年8月8日 | 日次 |
| ISCG · iShares Trust | 0.04% | 94,032 SH | 2026年8月8日 | 日次 |
| ITWO · ProShares Trust | 0.03% | 14,400 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.03% | 132,607 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 1,466,402 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 61,465 NS | 2026年5月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.02% | 874,372 SH | 2026年8月8日 | 日次 |
| ISCB · iShares Trust | 0.02% | 13,557 SH | 2026年8月8日 | 日次 |
| UWM · ProShares Trust | 0.02% | 11,261 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 135,688 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 638,128 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 11,390 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3,543,398 SH | 2026年8月8日 | 日次 |
| WSML · iShares Trust | 0.01% | 16,464 SH | 2026年8月8日 | 日次 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 12,000 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 286 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 452,118 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 27,701 NS | 2026年4月30日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 1,330 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 465,445 SH | 2026年8月8日 | 日次 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 196,006 NS | 2026年5月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 83,220 SH | 2026年8月8日 | 日次 |
| TILT · FlexShares Trust | 0.00% | 10,345 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 32,093 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 14,557 NS | 2026年4月30日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9,327,332 SH | 2026年8月8日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 26,184 SH | 2026年8月8日 | 日次 |